Find Out if Spravato Is Right for You, or Schedule an Appointment for a Consultation or Treatment at Aware Behavioral Health
Depression can have a significant impact on daily life, making it difficult to function at work, maintain relationships, or manage day-to-day responsibilities.
While traditional antidepressants and therapy are effective for many people, some individuals experience treatment-resistant depression (TRD), where standard treatments do not provide sufficient relief. In these situations, we have to examine whether or not there is a better option hat might provide relief.
TMS therapy is one option. Another option is known as “Spravato.”
Spravato (esketamine) is an innovative FDA-approved treatment for individuals with treatment resistant depression. As a nasal spray formulation of ketamine, Spravato works differently than traditional antidepressants by targeting glutamate receptors in the brain, helping to rapidly reduce depressive symptoms. Many patients experience improvement within hours to days, making it a promising option for those who have not responded to conventional treatments.
Aware Behavioral Health provides Spravato treatment in Grand Prairie, TX, with a convenient office location near Dallas, Bedford, Fort Worth, and other nearby areas. If other depression treatments have not worked for you, we can determine whether Spravato is a viable option to help you regain control of your mental health. Call us today at 469-487-7744 to learn more about Spravato therapy and schedule an appointment.
NOTE: WE HAVE RECENTLY OPENED A SECOND OFFICE FOR SPRAVATO TREATMENT IN IRVING, TX AT 2300 VALLEY VIEW LANE SUITE 601, IRVING, TX 75062. LET US KNOW IF YOU PREFER TREATMENT IN DALLAS OR IRVING.
How Does Spravato Treatment Work?
Unlike traditional antidepressants, which primarily target serotonin and norepinephrine, Spravato works on the glutamate system, a key neurotransmitter involved in mood regulation. By acting on the NMDA receptors, Spravato enhances synaptic connections in the brain, helping to alleviate depressive symptoms quickly.
Spravato treatment is administered in-office under medical supervision due to the potential for side effects such as dissociation and increased blood pressure. The treatment process involves:
- Pre-Treatment Assessment – Before treatment begins, we evaluate your medical history, current medications, and past treatment response to ensure Spravato is a suitable option for you.
- Nasal Spray Administration – Patients self-administer the nasal spray under the supervision of a healthcare provider. The medication is absorbed through the nasal passages and begins working within hours.
- Observation Period – After administration, you remain in the office for at least two hours for monitoring. During this time, we assess for side effects and ensure a safe response to treatment.
- Post-Treatment Recovery – Because Spravato can cause temporary dizziness or dissociation, you will need a trusted person to drive you home after each session.
Spravato treatment typically follows a structured schedule:
- Induction Phase (Weeks 1-4) – Two treatments per week.
- Maintenance Phase (Weeks 5-8 and beyond) – One treatment per week or every two weeks, depending on response.
Spravato is only one option for treatment resistant depression, but it is a very effective one that many people are finding provides them with the relief they were lacking from other treatments.
Benefits of Spravato for Treatment-Resistant Depression
Spravato has been extensively studied for its effectiveness in individuals who have not responded to conventional antidepressants, and it has been found to be a very effective option when other options are not working out as expected. Some of the benefits of Spravato include:
- Rapid Relief – Unlike traditional antidepressants, which may take weeks to take effect, Spravato can provide relief in hours to days for some patients.
- Different Mechanism of Action – By targeting glutamate receptors, Spravato offers an alternative approach for those who have not benefited from serotonin-based treatments.
- FDA-Approved for TRD – Spravato is one of the few medications specifically approved for treatment-resistant depression, backed by clinical research and regulatory approval.
- Supervised Administration for Safety – Unlike other medications, Spravato is administered in a controlled environment, ensuring patient safety during treatment.
Not all patients are suitable for Spravato treatment. We will assess your medical history and current health conditions before recommending this treatment. Spravato may not be recommended for individuals with:
- A history of psychosis or schizophrenia.
- Uncontrolled high blood pressure.
- Certain cardiovascular conditions.
- Substance use disorders, as ketamine-based treatments have a potential for misuse.
It’s also not the only option. There are other medications and TMS therapy, both of which are also good choices that might be right for specific individuals. Each case is different, and it will be important to discuss your needs with Aware Behavioral Health to determine what option is best for you.
Why Choose Aware Behavioral Health for Spravato Therapy?
At Aware Behavioral Health, we are committed to providing the latest, evidence-based treatments for depression and other mental health conditions. Dr. Sehdev has extensive experience in treating depression and works closely with each patient to determine the most effective approach.
Our team will evaluate your history, discuss your treatment goals, and create a personalized plan that may include Spravato, medication management, and therapy to help you achieve lasting improvement.
If you are struggling with treatment-resistant depression and want to explore Spravato as an option, contact Aware Behavioral Health today. Call 469-487-7744 to schedule a consultation at our Dallas or Irving office and take the next step toward relief.